123 related articles for article (PubMed ID: 2535259)
1. High dose nicotinamide fails to prevent diabetes in BB rats.
Hermitte L; Vialettes B; Atlef N; Payan MJ; Doll N; Scheimann A; Vague P
Autoimmunity; 1989; 5(1-2):79-86. PubMed ID: 2535259
[TBL] [Abstract][Full Text] [Related]
2. The effects of nicotinamide and glimepiride on diabetes prevention in BB rats.
Pan J; Chan EK; Cheta D; Schranz V; Charles MA
Life Sci; 1995; 57(16):1525-32. PubMed ID: 7564897
[TBL] [Abstract][Full Text] [Related]
3. Protective effect of 3-aminobenzamide, an inhibitor of poly (ADP-ribose) synthetase, against streptozotocin-induced diabetes.
Masiello P; Cubeddu TL; Frosina G; Bergamini E
Diabetologia; 1985 Sep; 28(9):683-6. PubMed ID: 2933287
[TBL] [Abstract][Full Text] [Related]
4. Nicotinamide, a poly (ADP-ribose) synthetase inhibitor, ameliorates B-cell function in partially depancreatized rats.
Inoue Y; Tanigawa K; Nakamura S; Kato Y; Tamura K; Nakase A
Diabetes Res Clin Pract; 1993; 22(1):19-27. PubMed ID: 8137712
[TBL] [Abstract][Full Text] [Related]
5. The optimum dose of nicotinamide for protection of pancreatic beta-cells against the cytotoxic effect of streptozotocin in albino rat.
Hassan N; Janjua MZ
J Ayub Med Coll Abbottabad; 2001; 13(3):26-30. PubMed ID: 11873395
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of poly (ADP-ribose) synthetase by gene disruption or inhibition with 5-iodo-6-amino-1,2-benzopyrone protects mice from multiple-low-dose-streptozotocin-induced diabetes.
Mabley JG; Suarez-Pinzon WL; Haskó G; Salzman AL; Rabinovitch A; Kun E; Szabó C
Br J Pharmacol; 2001 Jul; 133(6):909-19. PubMed ID: 11454665
[TBL] [Abstract][Full Text] [Related]
7. Amelioration of diabetes mellitus in partially depancreatized rats by poly(ADP-ribose) synthetase inhibitors. Evidence of islet B-cell regeneration.
Yonemura Y; Takashima T; Miwa K; Miyazaki I; Yamamoto H; Okamoto H
Diabetes; 1984 Apr; 33(4):401-4. PubMed ID: 6323238
[TBL] [Abstract][Full Text] [Related]
8. Interleukin 2 receptor targeted immunotherapy in the prevention of autoimmune beta-cell destruction as observed in diabetic BB/OK rats grafted with BB/OK rat islets.
Hahn HJ; Kauert C; Dunger A; Kuttler B; Diamantstein T
Autoimmunity; 1989; 5(1-2):139-42. PubMed ID: 2519014
[No Abstract] [Full Text] [Related]
9. Protection by 3-aminobenzamide and nicotinamide against streptozotocin-induced beta-cell toxicity in vivo and in vitro.
Masiello P; Novelli M; Fierabracci V; Bergamini E
Res Commun Chem Pathol Pharmacol; 1990 Jul; 69(1):17-32. PubMed ID: 2145620
[TBL] [Abstract][Full Text] [Related]
10. Nicotinamide does not protect islet B-cell metabolism against alloxan toxicity.
Sandler S; Welsh M; Andersson A
Diabetes; 1984 Oct; 33(10):937-43. PubMed ID: 6237009
[TBL] [Abstract][Full Text] [Related]
11. DNA strand breaks and poly(ADP-ribose) synthetase activation in pancreatic islets--a new aspect to development of insulin-dependent diabetes and pancreatic B-cell tumors.
Okamoto H; Yamamoto H
Princess Takamatsu Symp; 1983; 13():297-308. PubMed ID: 6317640
[TBL] [Abstract][Full Text] [Related]
12. Protection by thymidine, an inhibitor of polyadenosine diphosphate ribosylation, of streptozotocin inhibition of insulin secretion.
Bolaffi JL; Nagamatsu S; Harris J; Grodsky GM
Endocrinology; 1987 May; 120(5):2117-22. PubMed ID: 2952491
[TBL] [Abstract][Full Text] [Related]
13. Effect of nicotinamide on experimental induced diabetes.
Alenzi FQ
Iran J Allergy Asthma Immunol; 2009 Mar; 8(1):11-8. PubMed ID: 19279354
[TBL] [Abstract][Full Text] [Related]
14. Loss of insulin response to glucose but not arginine during the development of autoimmune diabetes in BB/W rats: relationships to islet volume and glucose transport rate.
Tominaga M; Komiya I; Johnson JH; Inman L; Alam T; Moltz J; Crider B; Stefan Y; Baetens D; McCorkle K
Proc Natl Acad Sci U S A; 1986 Dec; 83(24):9749-53. PubMed ID: 3540950
[TBL] [Abstract][Full Text] [Related]
15. Effect of poly(ADP-ribose) synthetase inhibitor administration to rats before and after injection of alloxan and streptozotocin on islet proinsulin synthesis.
Uchigata Y; Yamamoto H; Nagai H; Okamoto H
Diabetes; 1983 Apr; 32(4):316-8. PubMed ID: 6299867
[TBL] [Abstract][Full Text] [Related]
16. Effect of poly(ADP-ribose) synthetase inhibitor administration to streptozotocin-induced diabetic rats on insulin and glucagon contents in their pancreas.
Shima K; Hirota M; Sato M; Numoto S; Oshima I
Diabetes Res Clin Pract; 1987; 3(3):135-42. PubMed ID: 2954803
[TBL] [Abstract][Full Text] [Related]
17. Long-term effects of nicotinamide-induced inhibition of poly(adenosine diphosphate-ribose) polymerase activity in rat pancreatic islets exposed to interleukin-1 beta.
Reddy S; Salari-Lak N; Sandler S
Endocrinology; 1995 May; 136(5):1907-12. PubMed ID: 7720637
[TBL] [Abstract][Full Text] [Related]
18. Ex vivo gene transfer of viral interleukin-10 to BB rat islets: no protection after transplantation to diabetic BB rats.
Kuttler B; Wanka H; Klöting N; Gerstmayer B; Volk HD; Sawitzki B; Ritter T
J Cell Mol Med; 2007; 11(4):868-80. PubMed ID: 17760846
[TBL] [Abstract][Full Text] [Related]
19. Protective effect of gamma-hydroxybutyrate and nicotinamide on low-dose streptozotocin-induced diabetes in mice.
Bouix O; Reynier M; Guintrand-Hugret R; Orsetti A
Horm Metab Res; 1995 May; 27(5):216-20. PubMed ID: 7642171
[TBL] [Abstract][Full Text] [Related]
20. Cholecystokinin octapeptide: a potential growth factor for pancreatic beta cells in diabetic rats.
Kuntz E; Pinget M; Damgé P
JOP; 2004 Nov; 5(6):464-75. PubMed ID: 15536283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
